Key result
Home blood pressure monitoring recorded approximately 20% smaller reductions from antihypertensive treatments than clinic blood pressure (-12.2 vs -15.2 mm Hg for systolic BP; r=0.66, P<0.001).
Why the study?
How do treatment-induced changes in home blood pressure compare with changes in clinic blood pressure in patients receiving antihypertensive treatments?
Meta-Analysis (n=6,794)
How do treatment-induced changes in home blood pressure compare with changes in clinic blood pressure in patients receiving antihypertensive treatments?
Antihypertensive treatments reduce home blood pressure approximately 20% less than clinic blood pressure, which is critical for accurately interpreting treatment efficacy when using home monitoring.
Home BP yields smaller treatment effects than clinic readings; reinforces modality-specific thresholds for response assessment in trials and practice.
Home blood pressure (HBP) monitoring is recommended for assessing the effects of antihypertensive treatment, but it is not clear how the treatment-induced changes in HBP compare with the changes in clinic blood pressure (CBP). We searched PubMed using the terms "home or self-measured blood pressure," and selected articles in which the changes in CBP and HBP (using the upper arm oscillometric method) induced by antihypertensive drugs were presented. We performed a systematic review of 30 articles published before March 2008 that included a total of 6794 subjects. As there was significant heterogeneity in most of the outcomes, a random effects model was used for the meta-analyses. The mean changes (+/-SE) in CBP and HBP (systolic/diastolic) were -15.2+/-0.03/-10.3+/-0.03 mm Hg and -12.2+/-0.04/-8.0+/-0.04 mm Hg respectively, although there were wide varieties of differences in the reduction between HBP and CBP. The reductions in CBP were correlated with those of HBP (systolic BP; r=0.66, B=0.48, diastolic BP; r=0.71, B=0.52, P<0.001). In 7 studies that also included 24-hour BP monitoring, the reduction of HBP was greater than that of 24-hour BP in systolic (HBP; -12.6+/-0.06 mm Hg, 24-hour BP; -11.9+/-0.04 mm Hg, P<0.001). In 5 studies that included daytime and nighttime systolic BP separately, HBP decreased 15% more than daytime ambulatory BP and 30% more than nighttime ambulatory BP. In conclusion, HBP falls approximately 20% less than CBP with antihypertensive treatments. Daytime systolic BP falls 15% less and nighttime systolic BP falls 30% less than home systolic BP.
No takes yet. Share an insight, caveat, or question.
Ishikawa et al. (2008) conducted a meta-analysis in Hypertension (n=6,794). Home blood pressure (HBP) monitoring vs. Clinic blood pressure (CBP) monitoring was evaluated on Treatment-induced change in systolic blood pressure (mm Hg) (r=0.66, p=<0.001). Home blood pressure monitoring recorded approximately 20% smaller reductions from antihypertensive treatments than clinic blood pressure (-12.2 vs -15.2 mm Hg for systolic BP; r=0.66, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: